Dr. Soukas has been actively involved as a site principal investigator in the field of carotid stenting. He was the leading New England enroller in the NINDS-sponsored landmark CREST Trial, a randomized trial of endarterectomy vs. stenting with embolic protection. He's been a site investigator in the EPIC, SONOMA, PROTECT, SAPPHIRE, SAPPHIRE-WW, EXACT, ARCHER, CREATE, CREATE-PAS, CARES, CHOICE, EMBOLDEN, CASES, FREEDOM and CANOPY carotid stent trials.
Dr. Soukas has been involved in the the evaluation of renal artery stenting and embolic protection. He's been a site investigator for the CORAL, Florence and VIVA-Fortress renal trials, and will be a site investigator in the ARTISAN renal stent trial to evaluate the safety and efficacy of covered stents for the treatment of renal artery stenosis.
Dr. Soukas has been actively involved in the evaluation of novel treatments for the treatment of lower extremity disease. He's been a site principal investigator in the Superb, Bioflex, VIPER and Open trials, to evaluate novel stent designs for the femoro-popliteal arterial segment, and will be investigating the novel Tigris stent in an upcoming trial. He's been a site PI for the Definitive-LE trial evaluating the role of plaque excisional atherectomy. Dr. Soukas is a site PI for the PEARL registry for the treatment of arterial and venous thrombosis using mechanical thrombectomy, and will be investigating the role of ultrasound-assisted thrombolysis for the treatment of pulmonary embolism in patients with submissive pulmonary embolism.